Top Markets
#1 Velas Velas +562.78%
#2 Polymath Polymath +529.94%
#3 Galxe Galxe +96.05%
#4 XION XION +63.34%
#5 Resolv wstUSR Resolv wstUSR +59.11%
#6 Nomina Nomina +45.78%
#7 Cofinex Cofinex +26.87%
#8 Swarms Swarms +16.74%
#9 Unibase Unibase +15.72%
#10 Cysic Cysic +14.51%
Coin of the day
Velas Velas
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Exscientia plc Exscientia plc

Exscientia plc

EXAI
Rangering i aksjer #99999
Exscientia plc, an artificial intelligence-driven pharmatech company, engages... Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.
Aksjekurs
$4.84
Markedsverdi
$633.18M
Endring (1 dag)
3.20%
Endring (1 år)
0.00%
Land
GB
Handel Exscientia plc (EXAI)

Kategori

Healthcare
Antall utestående aksjer for Exscientia plc (EXAI)
Antall utestående aksjer per September 2024: 126.59M
Ifølge Exscientia plc sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 126.59M. Ved slutten av December 2022 hadde selskapet 122.12M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Exscientia plc (EXAI) fra 2019 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
2026 (TTM) 126.59M 1.93%
2023 124.20M 1.70%
2022 122.12M 1.02%
2021 120.89M 0.41%
2020 120.39M 0.00%
2019 120.39M 0.00%
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 4.45B 3,413.46%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 100.56%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 102.90M -18.72%
US
UCB SA UCB SA
UCB SA
UCB.BR
 190.00M 50.08%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
 483.58M 281.99%
AU